Oligonucleotide delivery is moving beyond the liver. Patent filings, clinical progress and deal activity now point to muscle as the leading extrahepatic frontier, with new approaches also emerging for the brain, lung and other hard-to-reach tissues. The post Beyond the Liver: What the Filing Data Shows About Oligonucleotide Delivery in 2026 appeared first on Patsnap .
Discovery
Learnings
- auto_storiesStories
- categoryAreas
- helpFAQ
- forumConversations
- descriptionPapers
- mailNewsletters
- video_libraryVideos
- timelineTimeline
Guidance
- codeTechnology of APIs
- business_centerBusiness of APIs
- campaignEvangelism of APIs
- gavelGovernance of APIs
- historyHistory of APIs
- account_balancePolitics of APIs
Toolbox
- domainProviders
- apiAPIs
- cloudSolutions
- buildTools
- verifiedStandards
- gavelRegulations
- horizontal_ruleHeaders
- layersOverlays
- extensionExtensions
- schemaSchema
- policyPolicies
- ruleRules